Status:
COMPLETED
Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen
Lead Sponsor:
Hamdard University
Conditions:
H.Pylori Infection
Eligibility:
All Genders
15+ years
Phase:
PHASE2
PHASE3
Brief Summary
Helicobacter pylori (H. pylori) is a bacterium its infection is regarded the most common medical condition associated with gastritis1 more over peptic ulcer disease2, gastric adenocarcinoma3 and lymph...
Detailed Description
Helicobacter pylori (H. pylori) is a bacterium its infection is regarded the most common medical condition associated with gastritis1 more over peptic ulcer disease2, gastric adenocarcinoma3 and lymph...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The individuals suffering from H. pylori infection .
- Individuals having no previous history of H. pylori infection treatment.
- Individuals living in Karachi.
- Individuals with no pathological finding on routine examination.
- Individuals from either socioeconomic class including lower, middle and higher.
- Both male and female individuals between 14 to 55 years of age
- Subjects with informed written consent
- Patients having no complications regarding other than GIT system.
- Exclusion Criteria
- The following were the reason for excluding the individuals from this trial:
- Patient with simultaneous physical illness, for example renal dialysis and uncontrolled diabetes mellitus.
- Individuals having stomach or intestinal surgical history were excluded.
- Individuals with past record of any herbal or allopathic medication were excluded
- Individuals with hyper sensitivity history of drug or adverse reaction to any of the study drugs .
- Females with pregnancy were also excluded for the safety measures
- Individuals with coma, meningitis, and encephalitis or head injury were also excluded.
- Hospitalized individuals due to any serious diseases were excluded.
- Individuals with known poor compliance and history of drug abuse were excluded.
Exclusion
Key Trial Info
Start Date :
January 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03837210
Start Date
January 5 2017
End Date
January 10 2019
Last Update
February 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.